Stay informed by tuning in to our premium podcast, hosted by our in-house specialists Endre Szvetnik and Dr. Talia Henkle.
In 10 seconds? Will it spread or not? That is the question for many cancer patients. Certain circular RNA molecules could one day help make more reliable cancer diagnoses. Why are we talking about this? Cancer is most deadly when...
In 10 seconds? Clinical trial results provide the latest data on new cancer treatment options but are usually riddled with cryptic terminology. In this Cancer 101 digest, we distill the most common terms used to assess clinical tr...
In 10 seconds? New data shows that screening and treatment procedures can successfully prevent the formation of anal cancer. Wow, that’s good news! How can anal cancer be prevented? It’s pretty much common knowledge that cancer i...
In 10 seconds? Bi-specific T cell engagers (BiTEs) are an emerging cancer treatment strategy that work both to activate anti-cancer T cells and pull them in to kill tumors. Wow, that sounds high-tech! And it is. BiTEs are essenti...
In 10 seconds? Battling cancer is physically and emotionally draining. What’s worse, is that for many Americans who have medical coverage under Medicare Part D, it can be financially draining as well. What’s the story? Medicare i...
In 10 seconds? Proton therapy is a type of cancer radiation therapy (radiotherapy) that can be a safer alternative to traditional X-ray radiation. At this stage, however, proton therapy is pricey and frequently difficult to access...
In 10 seconds? While overall quality of diet does not affect lack of attention, children with Attention deficit hyperactivity disorder (ADHD) that consume more fruits and vegetables have less severe inattention symptoms, according...
In 10 seconds? The Epstein-Barr virus (EBV) causes about 1.5% of all human cancers. Almost everyone is infected with EBV, but due to a wide range of interplaying environmental and genetic factors, only a small percentage develop E...
In 10 seconds? A cancer-fighting drug called an immune checkpoint inhibitor (specifically, anti-PD-1) was found to successfully treat 100% of rectal cancer patients in a study of 12 patients without the need for any other cancer t...